SCHEMBL10147809

SCHEMBL10147809

C=S(=O)(c1ccc(Cl)cc1)C(C)(C)c1nc(-c2cc(C(C)(C)C)on2)co1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.43
CNR1 P21554 3/20 0.43
ALDH1A1 P00352 3/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HTT P42858 3/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.33
BRD4 O60885 1/20 0.33
GAA P10253 1/20 0.32
KDM4E B2RXH2 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL350606 0.89 CNR2 (0.49) CNR2CNR1ALDH1A1MAPK1MEN1
SCHEMBL10147480 0.76 MEN1 (0.37) CNR2CNR1ALDH1A1MAPK1MEN1
SCHEMBL10146065 0.74 MEN1 (0.49) ALDH1A1MAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL1252445 0.74 CNR2 (0.41) CNR2CNR1ALDH1A1MAPK1MEN1
SCHEMBL13618544 0.70 MEN1 (0.45) MEN1KMT2ASMN1; SMN2HTTNPC1
SCHEMBL352017 0.69 CNR2 (0.52) CNR2CNR1ALDH1A1MAPK1MEN1
SCHEMBL19625484 0.67 MEN1 (0.69) CNR2CNR1ALDH1A1MAPK1MEN1
SCHEMBL10177216 0.63 MEN1 (0.45) MEN1KMT2ASMN1; SMN2HTTNPC1
SCHEMBL15121174 0.61 CNR2 (0.63) CNR2CNR1ALDH1A1MAPK1MEN1
SCHEMBL19625366 0.61 LTA4H (0.47) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418207-A1 Sulfone compounds which modulate the CB2 receptor Boehringer Ingelheim International GmbH (DE) 2012-02-15 EP disclosed